Hopital Edouard Herriot

Lyon Cedex 03

2 studies enrolling now · 30 studies all time

What they study most

Active Idiopathic Inflammatory Myopathy, Acute Kidney Injury, Acute Kidney Injury (AKI), Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Renal Allograft Rejection, Advanced Breast Cancer, Advanced Colorectal Cancer, Advanced Gastric Cancer, Advanced/Metastatic Non-Small Cell Lung Cancer, Antibody-mediated Rejection

Studies at this site

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer — Recruiting now
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN) — Recruiting now
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer — Completed
Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer — Stopped early
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer — Completed
Observational Study to Evaluate the Epidemiology of Surgical-induced Acute Kidney Injury — Completed
EndoRotor® Endoscopic Mucosal Resection System for the Colon — Completed
Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury — Stopped early
Spy II Clinical Registry — Completed
Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase — Completed
An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis — Completed
Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B — Completed
Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) — Completed
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. — Completed
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML — Completed
Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease — Completed
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis — Completed
A Study of Fabrazyme in Pediatric Patients With Fabry Disease — Completed
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients. — Completed
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) — Completed
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia — Completed
Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia — Completed
Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML) — Completed
A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D — Completed
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis — Completed
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients — Completed
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed
A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients — Completed